Discovery of C19-9 as a novel non-RGD inhibitor of αvβ3 to overcome enzalutamide resistance in castration-resistant prostate cancer.

ABSTRACT:

SUBMITTER: Pang X 

PROVIDER: S-EPMC9911763 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature